Tamsulosin Hydrochloride
Product Images NDC 67296-1913

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 67296-1913). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Label Tamsulosin 5026874015)

Packaging label for Tamsulosin Hydrochloride Capsules USP 0.4 mg, showing unit dose capsules in a 50 count package (5x10). The label includes storage instructions, dosage strength, and manufacturer information for Alkem Laboratories Ltd. and AvKARE, Inc. The design features red corner accents and the AV PAK logo.*

FDA Label Image

Tamsulosin-figure1 (Tamsulosin Figure1)

A pharmacokinetic line graph showing plasma concentration (ng/mL) of Tamsulosin Hydrochloride over time (hours). The graph compares plasma levels for fasted and fed states, with the fasted condition showing a higher peak concentration than the fed condition.*

FDA Label Image

Tamsu-fi2a (Tamsulosin Figure2a)

A line graph showing mean change over duration of treatment in weeks for three groups: 0.8 mg dosage, 0.4 mg dosage, and placebo. The x-axis represents weeks of treatment, while the y-axis shows mean change values. Data points for each group are connected by different styles of lines (dotted, dashed, solid) with corresponding symbols (circles, triangles, squares).*

FDA Label Image

Tamsu-fig2b (Tamsulosin Figure2b)

A line graph depicting mean change over the duration of treatment in weeks for three treatment groups: 0.8 mg, 0.4 mg, and placebo. The x-axis represents treatment duration from 0 to 13 weeks, and the y-axis shows mean change values. Distinct markers represent each treatment group with corresponding trend lines.*

FDA Label Image

Tamsu-fig3a (Tamsulosin Figure3a)

A line graph depicting mean change in urine flow rate (mL/sec) over a 13-week treatment period and a long-term open-label extension (LOCE). The graph compares three groups: 0.8 mg tamsulosin hydrochloride, 0.4 mg tamsulosin hydrochloride, and placebo. The x-axis shows duration in weeks, and the y-axis shows mean change values, with measured points and trend lines for each treatment group.*

FDA Label Image

Tamsu-fig3b (Tamsulosin Figure3b)

A line graph showing mean change in mL/sec on the y-axis versus duration of treatment in weeks on the x-axis. The graph compares three treatments labeled 0.8 mg, 0.4 mg, and placebo over time, with sample sizes noted for each time point. Data points depict the progression of outcomes throughout the study duration.*

FDA Label Image

Tamsulosin-structure (Tamsulosin Structure)

Chemical structure of Tamsulosin Hydrochloride showing its molecular framework including aromatic rings, methoxy groups, and hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.